搜尋
Kalvista Pharmaceuticals Inc
KALV添加自選
26.990USD
0.0000.00%
收盤 06/18, 16:00（美東）報價延遲15分鐘
1.44B總市值
虧損本益比TTM
股東統計
更新時間: 5月11日 週一
更新時間: 5月11日 週一
持股股東
股東類型
持股股東
持股股東
佔比
VR Adviser, LLC
12.25%
Frazier Life Sciences Management, L.P.
9.48%
Suvretta Capital Management, LLC
8.97%
Tang Capital Management, LLC
8.60%
BlackRock Institutional Trust Company, N.A.
5.60%
其他
55.10%
持股股東
持股股東
佔比
VR Adviser, LLC
12.25%
Frazier Life Sciences Management, L.P.
9.48%
Suvretta Capital Management, LLC
8.97%
Tang Capital Management, LLC
8.60%
BlackRock Institutional Trust Company, N.A.
5.60%
其他
55.10%
股東類型
持股股東
佔比
Hedge Fund
49.83%
Investment Advisor
35.94%
Investment Advisor/Hedge Fund
16.81%
Venture Capital
12.30%
Private Equity
10.20%
Research Firm
3.96%
Individual Investor
1.65%
Bank and Trust
0.22%
Pension Fund
0.12%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
350
74.08M
139.34%
+3.26M
2025Q4
322
62.90M
124.44%
-5.15M
2025Q3
304
58.90M
116.58%
-6.90M
2025Q2
293
60.52M
121.15%
-6.23M
2025Q1
300
56.85M
114.35%
-10.03M
2024Q4
295
57.02M
115.39%
-4.36M
2024Q3
292
50.23M
115.93%
-11.73M
2024Q2
292
49.87M
116.71%
-8.51M
2024Q1
293
49.24M
116.93%
-4.79M
2023Q4
269
38.06M
110.17%
-12.86M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
VR Adviser, LLC
6.51M
12.89%
-214.63K
-3.19%
Mar 26, 2026
Frazier Life Sciences Management, L.P.
5.04M
9.97%
+17.80K
+0.35%
Dec 31, 2025
Suvretta Capital Management, LLC
4.77M
9.43%
--
--
Dec 31, 2025
Tang Capital Management, LLC
4.57M
9.05%
-468.27K
-9.29%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.98M
5.89%
+243.25K
+8.89%
Dec 31, 2025
Capital World Investors
2.81M
5.56%
-369.00K
-11.61%
Dec 31, 2025
Point72 Asset Management, L.P.
2.78M
5.5%
+498.14K
+21.81%
Jan 05, 2026
SilverArc Capital Management, LLC
2.43M
4.8%
+1.06M
+78.02%
Dec 31, 2025
Emerald Advisers LLC
2.20M
4.34%
-73.27K
-3.23%
Dec 31, 2025
Woodline Partners LP
1.92M
3.8%
+428.00
+0.02%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
0.56%
Invesco NASDAQ Future Gen 200 ETF
0.43%
State Street SPDR S&P Biotech ETF
0.15%
Direxion Daily S&P Biotech Bull 3X Shares
0.09%
ProShares Ultra Nasdaq Biotechnology
0.09%
iShares Micro-Cap ETF
0.08%
Invesco Nasdaq Biotechnology ETF
0.05%
iShares Biotechnology ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.04%
Vanguard US Momentum Factor ETF
0.02%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.56%
Invesco NASDAQ Future Gen 200 ETF
佔比0.43%
State Street SPDR S&P Biotech ETF
佔比0.15%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.09%
ProShares Ultra Nasdaq Biotechnology
佔比0.09%
iShares Micro-Cap ETF
佔比0.08%
Invesco Nasdaq Biotechnology ETF
佔比0.05%
iShares Biotechnology ETF
佔比0.04%
Fidelity Enhanced Small Cap ETF
佔比0.04%
Vanguard US Momentum Factor ETF
佔比0.02%
